Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone and Metronidazole for Complicated Appendicitis in Children
NCT01678365Phase 4Completed
- Sponsor
- Emek Medical Center
- Start
- Jul 2008
- Primary completion
- Oct 2009
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ceftriaxone in appendicitis (2 arms), sponsored by Emek Medical Center. Primary endpoints: Length of Stay and Change of Primary Antibiotic Regimen to Piperacillin/Tazobactam. Started Jul 2008; status: completed.
02
Drugs
ceftriaxone
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT01678365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678365.